SCHEMBL1284491

SCHEMBL1284491

CCOCc1cc2ccccc2oc1=Nc1ccc(Cl)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
AGXT P21549 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
SLC6A4 P31645 1/20 0.34
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284490 1.00 MAPT (0.37) MAPTLMNAHPGDALOX15TSHR
SCHEMBL1284938 0.90 AGXT (0.40) MAPTHPGDHTTAGXTTDP1
SCHEMBL1284937 0.90 AGXT (0.40) MAPTHPGDHTTAGXTTDP1
SCHEMBL1285404 0.89 KDM4E (0.39) TSHRL3MBTL1ALDH1A1KMT2ACYP1A2
SCHEMBL1285402 0.89 KDM4E (0.39) TSHRL3MBTL1ALDH1A1KMT2ACYP1A2
SCHEMBL1284660 0.88 MAOB (0.40) AGXTALDH1A1KMT2AMEN1CYP1A2
SCHEMBL1285390 0.88 CA12 (0.39) MAPTHPGDTSHRAGXTL3MBTL1
SCHEMBL1284663 0.88 MAOB (0.40) AGXTALDH1A1KMT2AMEN1CYP1A2
SCHEMBL1285467 0.88 MAPT (0.40) MAPTTSHRAGXTL3MBTL1ALDH1A1
SCHEMBL1285468 0.88 MAPT (0.40) MAPTTSHRAGXTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 MAPT 4232/4885LMNA 338/4885HPGD 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.